Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
After 14 days of treatment, the mice were euthanized via cardiac injection of sodium pentobarbitone given at 35 mg/kg
It had bought Barr Pharmaceuticals in 2008, and Barr then bought Pliva in 2006
The distributor, manufacturer, and seller of this product disclaim any responsibility for its misuse or any resulting consequences
AOD 9604 doesn't affect IGF-1 levels, so there's no concern about unwanted tissue growth or increased cancer risk
Property Detail Full Name Body Protection Compound 157 Amino Acids 15 (pentadecapeptide) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1,419 g/mol Forms reviewed by FDA Free base and acetate salt FDA Status Not approved Active IND applications None (as of April 2026) Compounding status Under reclassification review (July 23-24, 2026) Is BPC-157 FDA Approved in 2026
US$ 25.95
US$ 22.71
US$ 23.26
US$ 28.75
US$ 28.83
US$ 23.55
